In this section
Clinical trials
- Participate in a clinical trial
- For medical professionals
- Active clinical trials for pediatric cancers
- CAR-20/19-T cells in pediatric and young adult patients with relapsed/refractory B Cell Acute Lymphoblastic Leukemia (CAR-20/19-T) phase 1 clinical trial
- Unrelated and partially matched related donor peripheral stem cell transplantation for patients with hematologic malignancies clinical trial
- Early stage research
Active clinical trials
Cancer Clinical Trials - COG-APEC1621SC
Protocol Summary
- Protocol No
- COG-APEC1621SC
- Principal Investigator
- Paul Harker-Murray
- Phase
- II
- Title
- NCI - COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
- Associated Disease(s)
-
Early Phase Trials (Phase I and II)
- Description (Summary)
- This study aims to utilize clinical data along with tumor specimens to screen for eligibility to phase 2 pathway-targeting specific subprotocols of pathway-targeting agents in pediatric patients with advance solid tumors, non-hodgkin lymphomas, and histiocytic disorders.
- Participating Institutions
- Childrens Hospital of Wisconsin
- ClinicalTrials.gov
Contact us
For more information about cancer and blood disorders clinical trials, email us or call
(414) 955-4727
Get a second opinion
It's important to know what your options are. We can provide expert opinions to verify or give more information about an initial diagnosis. Contact us today.
Why participate in clinical trials?
